3-甲基苯磺酰基异氰酸酯 | 194543-40-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-甲基苯磺酰基异氰酸酯
• 英文名称: 3-methylbenzenesulfonyl isocyanate
• 英文别名: 3-Methylbenzene-1-sulfonyl isocyanate；3-methyl-N-(oxomethylidene)benzenesulfonamide
• CAS: 194543-40-3
• 化学式: C₈H₇NO₃S
• mdl: MFCD16304425
• 分子量: 197.214
• InChiKey: NRPHEJYDQNWSJF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  72
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-甲基苯磺酰基异氰酸酯 在 水 作用下， 生成 间甲苯磺胺
  参考文献：
  名称：

  Tin for organic synthesis. 10. Unconventional regiospecific syntheses of aromatic carbonamides and thiocarbonamides by means of tin-mediated Friedel-Crafts reactions

  摘要：

  Friedel-Crafts reactions of stannylarenes 1 with tosyl isocyanate (TsNCO, 2) give N-tosylcarbonamides 3 via ipso substitution of the stannyl group. Thus, unconventionally substituted aromatic carbonamides can be obtained. The combination of the reaction of 1 and 2 with that of 1 and chlorosulfonyl isocyanate (14) allows one-pot syntheses of N-(arylsulfonyl)-substituted aromatic carbonamides with optional substitution patterns on both aromatic rings. The known ipso-specific substitutions of stannylarenes with 14 are extended to bi- and tricyclic arenes as well as to thiophenes 6 and 22. One stannyl group can serve as a leaving group for two aromatic systems, as shown with diaryldialkyltins 29. Also, stannylalkanes such as 27 react with 14 to afford alkylsulfonyl isocyanates and products of further reactions, such as 28. From the reactions of 1 with ethoxycarbonyl isothiocyanate (32), ortho- and meta-substituted aromatic thiocarbonamides 33 which are potential precursors for further syntheses, are accessible. The scope, limitations, and mechanism of these electrophilic substitutions are outlined.

  DOI：

  10.1021/jo00077a020
• 作为产物：
  描述：

  氯磺酰异氰酸酯 、 三丁基(3-甲基苯基)锡烷 以 二氯甲烷 为溶剂， 反应 15.0h， 生成 3-甲基苯磺酰基异氰酸酯
  参考文献：
  名称：

  Arnswald, Martin; Neumann, Wilhelm P., Chemische Berichte, 1991, vol. 124, # 9, p. 1997 - 2000

  摘要：

  DOI：

文献信息

• INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
  申请人：ViiV Healthcare UK (No.5) Limited

  公开号：US20170304239A1

  公开（公告）日：2017-10-26

  Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

  公式I的化合物，包括其药用可接受的盐，以及用于治疗人类免疫缺陷病毒（HIV）感染的组合物和方法被阐明：
• SULFONYLUREIDOPYRAZOLE DERIVATIVES
  申请人：SUMITOMO PHARMACEUTICALS COMPANY, LIMITED

  公开号：EP0885890A1

  公开（公告）日：1998-12-23

  A sulfonylureidopyrazole derivative of formula (1) or (2) is disclosed. The derivative has an inhibitory activity on endothelin converting enzyme, and is useful for treating or preventing various cardiac failures, tracheal constrictions, nervous disorders, parasecretion, vascular disorders, various ulcers and the like.

  公开了一种化学式（1）或（2）的磺酰脲吡唑衍生物。该衍生物对内皮素转化酶具有抑制活性，可用于治疗或预防各种心脏衰竭、气管收缩、神经紊乱、副分泌、血管紊乱、各种溃疡等疾病。
• Ion Channel Modulators & Uses Thereof
  申请人：Lawton Geoff

  公开号：US20090318423A1

  公开（公告）日：2009-12-24

  Compounds of general formula (1) and pharmacologically acceptable salts and prodrugs thereof: Formula (1) wherein A and B are CH 2 or CH 2 CH 2 , R1 is hydrogen, alkyl, cycloalkyl, aryl, aralkyl or heteroaralkyl, R2, R3 and R4 are selected from hydrogen, alkyl, halogen, haloalkyl, alkoxy, alkoxycarbonyl, carboxyl, hydroxyl or cyano; X is R5CO, R5SO 2 , R5R7NCO, R5R7NSO 2 , R5SO 2 NR7CO or CO 2 R8, Y is R6CO, R6SO 2 , R6R7NCO, R6R7NSO 2 , R6SO 2 NR7CO or CO 2 R8, R5 and R6 are hydrogen, alkyl, aryl, aralkyl, heteroaryl or heteroaralkyl, R7 is hydrogen, alkyl, aryl or aralkyl, and R8 is alkyl, aryl, aralkyl, alkoxyalkyl, heteroaryl or heteroarylalkyl, are of use in the prophylaxis or treatment of diseases and conditions in which Kv1.x channels are involved, such as lower urinary tract disorders, cardiovascular diseases and pain.

  通式（1）及其药理学上可接受的盐和前药的化合物：公式（1）中，A和B是CH2或CH2CH2，R1是氢，烷基，环烷基，芳基，芳基烷基或杂芳基烷基，R2，R3和R4从氢，烷基，卤素，卤代烷基，烷氧基，烷氧羰基，羧基，羟基或氰基中选择；X是R5CO，R5SO2，R5R7NCO，R5R7NSO2，R5SO2NR7CO或CO2R8，Y是R6CO，R6SO2，R6R7NCO，R6R7NSO2，R6SO2NR7CO或CO2R8，R5和R6是氢，烷基，芳基，芳基烷基，杂芳基或杂芳基烷基，R7是氢，烷基，芳基或芳基烷基，R8是烷基，芳基，芳基烷基，烷氧基烷基，杂芳基或杂芳基烷基，用于预防或治疗Kv1.x通道参与的疾病和病状，如下尿路疾病，心血管疾病和疼痛。
• Use of Ion Channel Modulators in the Prophylaxis and Treatment of Inflammatory and Immunological Diseases
  申请人：Lawton Geoff

  公开号：US20110130383A1

  公开（公告）日：2011-06-02

  Use of compounds of general formula (1) and pharmacologically acceptable salts and prodrugs thereof: Formula (1) wherein A and B are CH 2 or CH 2 CH 2 , R1 is hydrogen, alkyl, cycloalkyl, aryl, aralkyl or heteroaralkyl, R2, R3 and R4 are selected from hydrogen, alkyl, halogen, haloalkyl, alkoxy, alkoxycarbonyl, carboxyl, hydroxyl or cyano; X is R5CO, R5SO 2 , R5R7NCO, R5R7NSO 2 , R5SO 2 NR7CO or CO 2 R8, Y is R6CO, R6SO 2 , R6R7NCO, R6R7NSO 2 , R6SO 2 NR7CO or CO 2 R8, R5 and R6 are hydrogen, alkyl, aryl, aralkyl, heteroaryl or heteroaralkyl, R7 is hydrogen, alkyl, aryl or aralkyl, and R8 is alkyl, aryl, aralkyl, alkoxyalkyl, heteroaryl or heteroarylalkyl, provided that when X is R5CO or R5SO 2 , then Y is not R6CO, R6SO 2 or R6R7NCO, in the manufacture of a medicament for the prophylaxis or treatment of inflammatory or immunological disease.

  通式（1）及其药理学上可接受的盐和前药的化合物的使用：式（1）其中A和B是CH2或CH2CH2，R1是氢，烷基，环烷基，芳基，芳基烷基或杂芳基烷基，R2、R3和R4从氢，烷基，卤素，卤代烷基，烷氧基，烷氧羰基，羧基，羟基或氰基中选择；X是R5CO，R5SO2，R5R7NCO，R5R7NSO2，R5SO2NR7CO或CO2R8，Y是R6CO，R6SO2，R6R7NCO，R6R7NSO2，R6SO2NR7CO或CO2R8，R5和R6是氢，烷基，芳基，芳基烷基，杂芳基或杂芳基烷基，R7是氢，烷基，芳基或芳基烷基，R8是烷基，芳基，芳基烷基，烷氧基烷基，杂芳基或杂芳基烷基，前提是当X是R5CO或R5SO2时，Y不是R6CO，R6SO2或R6R7NCO，用于预防或治疗炎症或免疫疾病的药物制剂的制造。
• Thiazolopyrimidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
  申请人：BAYER AG

  公开号：EP0348746A2

  公开（公告）日：1990-01-03

  Die vorliegende Erfindung betrifft neue Thiazolopyrimi­din-Derivate der allgemeinen Formel (I) in welcher R¹ für Wasserstoff oder Alkyl steht, R² für Wasserstoff, Alkyl oder gegebenenfalls substi­tuiertes Aryl steht, R³ für jeweils gegebenenfalls substituiertes Alkyl, Cycloalkyl, Aryl, Arylcarbonyl oder Arylsulfonyl steht, und X für Sauerstoff oder Schwefel steht, welche als Schädlingsbekämpfungsmittel verwendet werden können.

  本发明涉及通式（I）的新型噻唑并嘧啶衍生物 其中 R¹代表氢或烷基 R²代表氢、烷基或任选取代的芳基、 R³ 在每种情况下都是任选取代的烷基、环烷基、芳基、芳基羰基或芳基磺酰基，以及 X 是氧或硫、 可用作杀虫剂。